Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Equity (2024 - 2025)

Historic Return on Equity for Mereo BioPharma (MREO) over the last 2 years, with Q3 2025 value amounting to 0.83%.

  • Mereo BioPharma's Return on Equity fell 2300.0% to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year decrease of 2300.0%. This contributed to the annual value of 0.78% for FY2024, which is 2000.0% down from last year.
  • Latest data reveals that Mereo BioPharma reported Return on Equity of 0.83% as of Q3 2025, which was down 2300.0% from 0.87% recorded in Q2 2025.
  • Mereo BioPharma's Return on Equity's 5-year high stood at 0.56% during Q1 2024, with a 5-year trough of 0.87% in Q2 2025.